Computationally unraveling how ceritinib overcomes drug-resistance mutations in ALK-rearranged lung cancer

Title
Computationally unraveling how ceritinib overcomes drug-resistance mutations in ALK-rearranged lung cancer
Authors
Keywords
Anaplastic lymphoma kinase (ALK), Molecular dynamics simulations, Ceritinib, MM-GBSA, Drug resistance
Journal
JOURNAL OF MOLECULAR MODELING
Volume 21, Issue 7, Pages -
Publisher
Springer Nature
Online
2015-06-17
DOI
10.1007/s00894-015-2716-z

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started